Article
Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
14 Jun 2021
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is a clinically diverse disease. Given the numerous genetic mutations and variations associated with it, a prognostic gene signature that can be related to the overall survival (OS) is a clinical implication. We used the mRNA expression profiles and clinicopathological data of patients with DLBCL from the Gene Expression Omnibus (GEO) database to identify a metabolism-related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
